RESUMEN
Objetivo Analizar los resultados del implante XEN45 en nuestro centro hospitalario, tanto en términos de eficacia como en cuanto a seguridad. Método Estudio observacional, retrospectivo y monocéntrico de los pacientes intervenidos de XEN45 en el Hospital Universitario de Jaén entre el 1 de enero de 2018 y el 31 de junio de 2021. Resultados Se implantó el dispositivo XEN45 a un total de 73 pacientes (48 cirugía combinada con facoemulsificación del cristalino y 25 de forma aislada). La PIO disminuyó de 19,9±4,9mmHg en la primera visita hasta una media de 17,1±5,3 (p=0,001) en el sexto mes. Se redujo de 2,1±0,9 a 0,6 el uso de fármacos necesarios entre la primera visita y el mes tras el implante XEN (p<0,000). Fue necesaria una segunda cirugía en 18 pacientes (26,6%) en los 6 primeros meses. Conclusiones La cirugía de glaucoma mediante implante XEN45, en solitario o combinado con la cirugía de catarata, es un procedimiento eficaz y seguro para la disminución de la PIO (AU)
Objective To analyze the results of the XEN45 implant in our hospital center, both in terms of efficacy and safety. Methods Observational, retrospective, single-center study of patients undergoing XEN45 surgery at the University Hospital of Jaén between January 1, 2018 and June 31, 2021. Results A total of 73 patients were implanted with the XEN45 device (48 with in combined surgery with phacoemulsification of the crystalline lens and 25 standalone XEN45 surgery). IOP decreased from 19.9±4.9mmHg at the first visit to a mean of 17.1±5.3 (P=.001) at the sixth month. Drug use required between the first visit and XEN implantation was reduced from 2.1±0.9 to 0.6 (P<.000). A second surgery was necessary in 18 patients (26.6%) in the first 6 months. Conclusions Glaucoma surgery by XEN45 implant, alone or combined with cataract surgery, is an effective and safe procedure for IOP lowering (AU)
Asunto(s)
Humanos , Masculino , Femenino , Anciano , Glaucoma/cirugía , Implantación de Lentes Intraoculares/métodos , Estudios Retrospectivos , Resultado del Tratamiento , Presión IntraocularRESUMEN
OBJECTIVE: To analyze the results of the Xen45 implant in our hospital center, both in terms of efficacy and safety. METHODS: Observational, retrospective, single-center study of patients undergoing Xen45 surgery at the University Hospital of Jaén between January 1, 2018 and June 31, 2021. RESULTS: A total of 73 patients were implanted with the Xen45 device (48 with in combined surgery with phacoemulsification of the crystalline lens and 25 standalone Xen45 surgery). IOP decreased from 19.9⯱â¯4.9â¯mmHg at the first visit to a mean of 17.1⯱â¯5.3 (Pâ¯=â¯.001) at the sixth month. Drug use required between the first visit and Xen implantation was reduced from 2.1⯱â¯0.9 to 0.6 (Pâ¯<â¯.000). A second surgery was necessary in 18 patients (26.6%) in the first 6 months. CONCLUSIONS: Glaucoma surgery by Xen45 implant, alone or combined with cataract surgery, is an effective and safe procedure for IOP lowering.
RESUMEN
Objetivo: El objetivo de este estudio es evaluar el tamaño de la glena en una población española normal, compararla con resultados previos en otras poblaciones y relacionarlo con los tamaños de implante que se comercializan para la artroplastia invertida de hombro. Material y métodos: Estudio antropométrico de la glena humana utilizando tomografías computarizadas de 154 pacientes con edades superiores a 30 años, realizados entre enero de 2015 y diciembre de 2017. Se valoran tomografías computarizadas de hombro con cortes de 2mm de grosor y 0mm de intervalo entre cortes, en algoritmo óseo y de partes blandas, realizándose reconstrucción 3D sobre la cual se obtienen mediciones de longitud y anchura de la glena. El punto superior de la glena se determinó en la zona superior del ovoide de la glena, en el tubérculo supraglenoideo, justo por debajo del reborde circunferencial que rodea la glena. El punto inferior se determinó como el punto más alejado del punto superior en el contorno de la glena, a nivel superior del reborde circunferencial que rodea la glena. Los puntos anterior y posterior fueron determinados como los extremos del eje transversal mayor en un plano perpendicular al eje superoinferior, por dentro del reborde circunferencial que rodea la glena. Las diferencias entre sexos, edad, altura, peso y relaciones de tamaños fueron evaluados. Resultados: La glena tiene un eje longitudinal medio de 28,78mm y una anchura de 20,27mm. Los valores del tamaño de la glena son significativamente diferentes en hombres y mujeres, siendo mayor en hombres. El tamaño de la glena está bien correlacionado con la estatura del paciente, existiendo una asociación positiva entre la estatura y la longitud y anchura de la superficie glenoidea. Las metaglenas circulares disponibles hoy en el mercado presentan tamaños no inferiores a 24-25mm de diámetro. Conclusión: La población del sur de España presenta un tamaño de la superficie glenoidea inferior a la población americana y semejante a la cohorte asiática. Los datos antropométricos expresados pueden ser útiles para la elección de la metaglena más apropiada en la población del sur de España
Objective: To evaluate the size of the glenoid in a southern Spanish population, to compare it with previous results from other populations and determine the size of the implants that are marketed for shoulder arthroplasty. Material and methods: Between January 2015 and December 2017, an anthropometrical study of the human glenoid was performed using computed axial tomography scans (CT) of 154 patients over 30 years old. The glenoid dimensions were analysed 3-dimensionally using 2mm interval thicknesses, determining the average height and width of the glenoid. The upper point of the glenoid geometry was determined as the supraglenoid tubercle of the ovoid glenoid surface, where the long head of the biceps tendon is thought to originate. The lower point was then positioned at the furthest point from the upper point on the glenoid contour. Anterior and posterior points were determined such that the 3-dimensional anterior-posterior distance was maximized on the plane perpendicular to the upper-lower axis. Sex differences and correlations between sides and among the respective parameters in the glenohumeral dimensions were also evaluated. Results: The glenoid had an average height of 28.78mm and width of 20.27mm. The values were significantly different between the men and the women, being greater in the men. The glenoid size is well correlated with the patient's size. Direct correlations exist between the glenoid height and width and the glenoid size and the patient's height. The available metaglenoids currently on the market are no bigger than 25-24mm. Conclusion: In comparison, the southern Spanish population have a glenoid size similar to the Caucasian population, but smaller than that of the American population. The data shown could be useful to improve the design of shoulder prostheses for the southern Spanish population
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Artroplastía de Reemplazo de Hombro/instrumentación , Cavidad Glenoidea/anatomía & histología , Diseño de Prótesis , Prótesis de Hombro , Cavidad Glenoidea/diagnóstico por imagen , Valores de Referencia , España , Tomografía Computarizada por Rayos XRESUMEN
OBJECTIVE: To evaluate the size of the glenoid in a southern Spanish population, to compare it with previous results from other populations and determine the size of the implants that are marketed for shoulder arthroplasty. MATERIAL AND METHODS: Between January 2015 and December 2017, an anthropometrical study of the human glenoid was performed using computed axial tomography scans (CT) of 154 patients over 30 years old. The glenoid dimensions were analysed 3-dimensionally using 2mm interval thicknesses, determining the average height and width of the glenoid. The upper point of the glenoid geometry was determined as the supraglenoid tubercle of the ovoid glenoid surface, where the long head of the biceps tendon is thought to originate. The lower point was then positioned at the furthest point from the upper point on the glenoid contour. Anterior and posterior points were determined such that the 3-dimensional anterior-posterior distance was maximized on the plane perpendicular to the upper-lower axis. Sex differences and correlations between sides and among the respective parameters in the glenohumeral dimensions were also evaluated. RESULTS: The glenoid had an average height of 28.78mm and width of 20.27mm. The values were significantly different between the men and the women, being greater in the men. The glenoid size is well correlated with the patient's size. Direct correlations exist between the glenoid height and width and the glenoid size and the patient's height. The available metaglenoids currently on the market are no bigger than 25-24mm. CONCLUSION: In comparison, the southern Spanish population have a glenoid size similar to the Caucasian population, but smaller than that of the American population. The data shown could be useful to improve the design of shoulder prostheses for the southern Spanish population.